The Global Protein G, L, and A Resin Market was valued at USD 778.90 Million in 2023 and is projected to reach USD 1326.27 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.90% during the forecast period (2025-2032). This robust growth is driven by surging demand for monoclonal antibody therapeutics, increasing biosimilar approvals, and the critical need for high-efficiency purification in biopharmaceutical manufacturing and advanced life sciences research.

As the biologics pipeline expands and therapeutic modalities become more complex, the spotlight falls on the affinity chromatography resins that are essential for isolating these precious molecules. In this blog, we profile the Top 10 Companies in the Protein G, L, and A Resin Industry—a dynamic mix of global life science leaders, specialty resin manufacturers, and process technology innovators shaping the future of bioprocessing.

---

🔟 1. Cytiva (Danaher Corporation)

Headquarters: Marlborough, Massachusetts, USA
Key Offering: MabSelect™, rProtein A, CaptivA™ Resins, Protein G Sepharose™

Cytiva is a global powerhouse in bioprocessing, offering one of the industry’s most extensive portfolios of affinity chromatography resins. Under the Danaher umbrella, its technologies, including the high-capacity MabSelect suite, are the gold standard for large-scale therapeutic antibody purification.

Innovation & Sustainability Initiatives:

• Continuous development of high-capacity, high-flow Protein A resins to improve manufacturing yield and efficiency.
• Investment in sustainable resin manufacturing processes and lifecycle management.
• Providing integrated solutions from lab-scale to commercial manufacturing through its Fast Trak services.

Download FREE Sample Report:
Protein G, L, And A Resin Market – View in Detailed Research Report

---

9️⃣ 2. Thermo Fisher Scientific

Headquarters: Waltham, Massachusetts, USA
Key Offering: Pierce™ Protein A/G/L Resins, ProPur™ IMAC Resins

Thermo Fisher Scientific provides a comprehensive range of resins for research-scale to process development applications. Its Pierce brand resins are widely used in labs worldwide for antibody purification and detection, while its cGMP-ready ProPur resins support larger-scale needs.

Innovation & Sustainability Initiatives:

• Focus on developing ready-to-use, pre-packed columns for method development and small-scale production.
• Emphasis on resin consistency and reproducibility to support robust scientific research.
• Commitment to reducing environmental impact through greener packaging and responsible sourcing.

---

8️⃣ 3. Merck KGaA (MilliporeSigma)

Headquarters: Darmstadt, Germany
Key Offering: Eshmuno® A, Protein A/G Sepharose®, Capto™ L Resins

Through its life science business MilliporeSigma, Merck KGaA is a critical supplier of chromatography solutions. The company offers high-performance resins like Eshmuno A, designed for superior capacity and stability, and Capto L for capturing antibody fragments and species not bound by Protein A or G.

Innovation & Sustainability Initiatives:

• Advancement of multi-modal and next-generation affinity ligands for challenging purification tasks.
• Strong focus on resin robustness to reduce costs and improve process economics in large-scale manufacturing.
• Investment in digital tools and services to optimize purification workflows.

---

7️⃣ 4. Repligen Corporation

Headquarters: Waltham, Massachusetts, USA
Key Offering: OPUS® Pre-packed Chromatography Columns, Protein A Ligands

Repligen has strategically positioned itself as a premier provider of bioprocessing technologies, focusing on intensified and continuous manufacturing. While not a resin manufacturer per se, its deep expertise in Protein A ligand development and its industry-leading OPUS pre-packed column platform make it a key technology enabler and partner for resin suppliers.

Innovation & Sustainability Initiatives:

• Pioneering continuous chromatography solutions that significantly reduce resin and buffer consumption.
• Developing high-flow, high-efficiency columns that maximize the performance of leading affinity resins.
• Driving process intensification to lower the environmental footprint of biologics production.

---

6️⃣ 5. Purolite Corporation (an Ecolab company)

Headquarters: King of Prussia, Pennsylvania, USA
Key Offering: Praesto® Protein A, G, and L Resins

Purolite, now part of Ecolab, brings decades of leadership in high-purity resins to the biopharma market. Its Praesto line of agarose and synthetic-based affinity resins is recognized for high dynamic binding capacity, excellent pressure-flow properties, and scalability from development to commercial manufacturing.

Innovation & Sustainability Initiatives:

• Development of advanced synthetic base matrices for superior resin durability and sanitization.
• Focus on resins that enable faster processing times and higher productivity.
• Integration with Ecolab’s global water and process hygiene technologies for complete bioprocess solutions.

Download FREE Sample Report:
Protein G, L, And A Resin Market – View in Detailed Research Report

---

5️⃣ 6. Bio-Rad Laboratories

Headquarters: Hercules, California, USA
Key Offering: Affi-Gel® Protein A, G, and L Resins, Nuvia™ cPrime Resins

Bio-Rad Laboratories is a trusted name in life science research, providing affinity resins for discovery and process development. Its Affi-Gel resins are staples in academic and industrial labs, while its Nuvia cPrime resins are engineered to meet the demands of pilot and production-scale purification.

Innovation & Sustainability Initiatives:

• Offering a wide selection of resin formats (beads, slurries, pre-packed) for flexible workflow integration.
• Developing resins with improved ligand stability to extend column lifetimes and reduce costs.
• Supporting the research community with comprehensive technical applications support.

---

4️⃣ 7. GenScript Biotech Corporation

Headquarters: Piscataway, New Jersey, USA
Key Offering: GenScript Protein A/G/L Resins, Recombinant Protein A

GenScript leverages its core expertise in gene synthesis and recombinant protein production to offer high-quality, cost-effective affinity resins. As a significant supplier of recombinant Protein A ligand to other resin manufacturers and directly to end-users, GenScript plays a vital role in the supply chain.

Innovation & Sustainability Initiatives:

• Competitive pricing that increases accessibility for research labs and emerging biotechs.
• Strong focus on quality control and batch-to-batch consistency for recombinant ligands.
• Vertical integration from gene synthesis to final resin product, enhancing supply chain security.

---

3️⃣ 8. Agilent Technologies

Headquarters: Santa Clara, California, USA
Key Offering: ProPac™ Protein A/G Columns, AdvanceBio Resins

Agilent Technologies is renowned for its analytical and preparative chromatography systems. Its ProPac Protein A and G columns are industry-standard tools for the analytical characterization and small-scale purification of antibodies, playing a crucial role in quality control and process analytics.

Innovation & Sustainability Initiatives:

• Developing highly reproducible analytical columns for precise monoclonal antibody characterization and impurity profiling.
• Integration of resin technology with advanced liquid chromatography (LC) instrumentation for seamless workflows.
• Commitment to providing high-resolution separation solutions that ensure product safety and efficacy.

---

2️⃣ 9. Abcam plc

Headquarters: Cambridge, United Kingdom
Key Offering: Protein A/G Ultralink® Resin, Protein L Agarose

Abcam is a global leader in the supply of research antibodies and associated reagents. Its portfolio includes high-quality Protein A, G, and L resins designed primarily for immunoprecipitation (IP), pull-down assays, and small-scale antibody purification in academic and biopharma research settings.

Innovation & Sustainability Initiatives:

• Specialization in resins optimized for maximum antigen-antibody complex recovery in research applications.
• Providing detailed protocols and expert support to the research community worldwide.
• Focus on supporting translational research that bridges discovery and therapeutic development.

---

1️⃣ 10. Kaneka Corporation

Headquarters: Osaka, Japan
Key Offering: Kaneka CapSure™ Protein A HC Resin

Kaneka, a Japanese chemical manufacturer, has made significant inroads into the bioprocessing market with its high-capacity CapSure Protein A resin. Known for its exceptional static and dynamic binding capacity, this resin offers a compelling alternative for manufacturers seeking to maximize productivity and reduce purification costs.

Innovation & Sustainability Initiatives:

• Continuous improvement of resin capacity and pressure/flow characteristics to support high-titer processes.
• Strategic partnerships with biopharma companies to co-develop optimized purification processes.
• Expanding its bioprocess footprint in the fast-growing Asia-Pacific biologics market.

Get Full Report Here:
Protein G, L, And A Resin Market – View in Detailed Research Report

---

🧪 Outlook: The Future of Antibody Purification Is High-Efficiency and Multi-Modal

The Protein G, L, and A resin market is evolving from a commodity supplier space into a sophisticated technology arena focused on intensification and novel modalities. While traditional resins still handle the bulk of IgG purification, the industry is investing heavily in next-generation ligands, improved base matrices, and integrated solutions to tackle emerging challenges.

📈 Key Trends Shaping the Market:

• Shift towards continuous biomanufacturing, requiring resins with superior stability and reusability.
• Rising demand for resins capable of purifying novel formats like bispecific antibodies, antibody-drug conjugates (ADCs), and fragments.
• Growing emphasis on cost of goods (COGs) reduction, driving innovation in resin capacity, lifetime, and recyclability.
• Increasing regulatory scrutiny on leachables, pushing the development of even more stable and robust ligand linkages.

Get Full Report Here:
Protein G, L, And A Resin Market – View in Detailed Research Report

The companies listed above are not only supplying the tools for purification—they’re enabling the safe, effective, and scalable production of the next generation of life-saving biotherapeutics.